- Home
- ZNTL vs NPT Comparison
ZNTL vs NPT Comparison
Compare ZNTL & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | NPT |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 126.9M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | NPT |
|---|---|---|
| Price | $3.25 | $6.09 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 71.7K |
| Earning Date | 11-10-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $26,865,000.00 | ★ $797,148,640.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.51 |
| 52 Week Low | $1.01 | $3.14 |
| 52 Week High | $3.95 | $9.18 |
Technical Indicators
Market Signals| Indicator | ZNTL | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 68.76 | N/A |
| Support Level | $2.80 | N/A |
| Resistance Level | $3.95 | N/A |
| Average True Range (ATR) | 0.42 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 70.91 | 0.00 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.